Abstract
G protein-coupled receptors (GPCRs) are the number one class of receptor targets for the pharmacotherapy of many pathological and disease states. This chapter presents an overview of the chapter topics presented in this new volume on the genetics of GPCRs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Collins F (2010) Has the revolution arrived? Nature 464:764–765
Lin HH (2013) G-protein-coupled receptors and their (Bio) chemical significance win 2012 Nobel Prize in Chemistry. Biomed J 36:118–124
Stevens CW (2014) Genetics of G protein-coupled receptor research and methods in the post-genomic era. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 3–22
Fredriksson R, Lagerström MC, Lundin LG (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256–1272
Stäubert C, Le Duc D, Schöneberg T (2014) Examining the dynamic evolution of G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 23–43
Hereld D, Devreotes PN (1992) The cAMP receptor family of Dictyostelium. Int Rev Cytol 137B:35–47
Buck L, Axel R (1991) A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 65:175–187
Spiess K, Rosenkilde MM (2014) Functional properties of virus-encoded and virus-regulated G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 45–65
Montaner S, Kufareva I, Abagyan R, Gutkind JS (2013) Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. Annu Rev Pharmacol Toxicol 53:331–354
White PC, McMillan DR (2014) Discovery and function of the very large G protein-coupled receptor. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 67–83
Suwa M, Sugihara M, Ono Y (2011) Functional and structural overview of G-protein-coupled receptors comprehensively obtained from genome sequences. Pharmaceuticals 4: 652–664
Vardy E, Stevens CW, Roth BL (2014) Functional evolution of the opioid family G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 85–104
Stevens CW (2003) Opioid research in amphibians: a unique perspective on mechanisms of opioid analgesia and the evolution of opioid receptors. Rev Analg 7:69–82
Stevens CW (2004) Opioid research in amphibians: an alternative pain model yielding insights on the evolution of opioid receptors. Brain Res Brain Res Rev 46:204–215
Stevens CW (2005) Molecular evolution of vertebrate opioid receptor proteins: a preview. In: Capasso A (ed) Recent developments in pain research. Research Signpost, Kerala
Stevens CW (2006) Opioid analgesia research in amphibians: from behavioral assay to cloning opioid receptor genes. Proc Annu Conf Assoc Reptile Amphib Vet 13:9–15
Stevens CW, Brasel CM, Mohan S (2007) Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals. Neurosci Lett 419:189–194
Stevens CW (2009) The evolution of vertebrate opioid receptors. Front Biosci 14: 1247–1269
Stevens CW (2011) Deciphering the molecular evolution of vertebrate G protein-coupled receptors. In: Stevens CW (ed) Methods for the discovery and characterization of G protein-coupled receptors, vol 60, Neuromethods. Humana Press/Springer Science+Business Media, LLC, New York, pp 71–102
Sundström G, Dreborg S, Larhammar D (2010) Concomitant duplications of opioid peptide and receptor genes before the origin of jawed vertebrates. PLoS One 5:e10512
Larhammar D, Dreborg S, Larsson TA et al (2009) Early duplications of opioid receptor and peptide genes in vertebrate evolution. Ann N Y Acad Sci 1163:451–453
Dreborg S, Sundström G, Larsson TA et al (2008) Evolution of vertebrate opioid receptors. Proc Natl Acad Sci U S A 105: 15487–15492
Noonan JP, Coop G, Kudaravalli S, Smith D et al (2006) Sequencing and analysis of Neanderthal genomic DNA. Science 314: 1113–1118
Meyer M, Kircher M, Gansauge MT et al (2012) A high-coverage genome sequence from an archaic Denisovan individual. Science 338:222–226
Willets JM, Nash C (2014) Investigation of G protein-coupled receptor function and regulation using antisense. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 105–126
Van Oekelen D, Luyten WH, Leysen JE (2003) Ten years of antisense inhibition of brain G-protein-coupled receptor function. Brain Res Brain Res Rev 42:123–142
Sandrasagra A, Tang L, Leonard SA et al (2001) RASONs: a novel antisense oligonucleotide therapeutic approach for asthma. Expert Opin Biol Ther 1:979–983
Altosaar K, Pétrin D, Devost D, Hébert TE (2014) Signalosome profiling reveals allosteric interactions between G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 127–146
Garland SL (2013) Are GPCRs still a source of new targets? J Biomol Screen: Aug 14, epub ahead of print
Masseck OA, Mark MD, Herlitze S (2014) Use of optogenetic approaches to control intracellular signaling of G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 149–160
Smith KS, Graybiel AM (2013) Using optogenetics to study habits. Brain Res 1511: 102–114
Steinberg EE, Janak PH (2013) Establishing causality for dopamine in neural function and behavior with optogenetics. Brain Res 1511:46–64
Porcellini A, Iacovelli L, De Blasi A (2014) Viral infection for G protein-coupled receptor expression in eukaryotic cells. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 161–175
Ali M, Lemoine NR, Ring CJ (1994) The use of DNA viruses as vectors for gene therapy. Gene Ther 1:367–384
Seregin SS, Amalfitano A (2009) Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Expert Opin Biol Ther 9:1521–1531
Sawyer GW, Ehlert FJ (2014) Using in vitro mutagenesis to characterize structure-function relationships in G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 177–195
Perez-Aguilar JM, Xi J, Matsunaga F (2013) A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor. PLoS One 8:e66009
Polites HG, Economides KD (2014) The CRE Luc mouse model for bioimaging ligand activation of G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 197–217
Scherrer G, Tryoen-Tóth P, Filliol D et al (2006) Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 103:9691–9696
Karnik SS, Unal H (2014) Inducing conformational changes in G protein-coupled receptors by domain coupling. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 219–237
Irannejad R, Tomshine JC, Tomshine JR et al (2013) Conformational biosensors reveal GPCR signalling from endosomes. Nature 495:534–538
Trehan A, Jonas K, Huhtaniemi I, Hanyaloglu A, Rivero-Müller A (2014) Rescue of defective G protein–coupled receptor function by intermolecular cooperation. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 239–255
Maya-Núñez G, Ulloa-Aguirre A, Janovick JA et al (2012) Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target. Subcell Biochem 63:263–289
Huang Y, Cavanaugh A, Breitwieser GE (2011) Regulation of stability and trafficking of calcium-sensing receptors by pharmacologic chaperones. Adv Pharmacol 62:143–173
Gurevich VV, Gurevich EV (2014) Design of super-arrestins for gene therapy of diseases associated with excessive signaling of G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 257–285
Ibrahim IA, Kurose HJ (2012) β-arrestin-mediated signaling improves the efficacy of therapeutics. J Pharmacol Sci 118:408–412
Lymperopoulos A (2012) Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors. Curr Pharm Des 18:192–198
Devaki R (2014) Importance of G protein-coupled receptor genetics in clinical medicine. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 289–298
Thompson MD, Percy ME, McIntyre Burnham W et al (2008) G protein-coupled receptors disrupted in human genetic disease. Methods Mol Biol 448:109–137
O’Hayre M, Vázquez-Prado J, Kufareva I (2013) The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 13:412–424
Jose PA, Villar VAM, Weir MR, Felder RA (2014) Pharmacogenomics of G protein-coupled receptor signaling and other pathways in essential hypertension. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 299–312
Thompson MD, Siminovitch KA, Cole DE (2008) G protein-coupled receptor pharmacogenetics. Methods Mol Biol 448:139–185
Johnson JA, Liggett SB (2011) Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions. Clin Pharmacol Ther 89:366–378
Karamitri A, Jockers R (2014) Exon sequencing of G protein-coupled receptor genes and perspectives for disease treatment. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 313–332
Nakamura K, Kodera H, Akita T et al (2013) De novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet: Aug 27, epub ahead of print
Teer JK, Mullikin JC (2010) Exome sequencing: the sweet spot before whole genomes. Hum Mol Genet 19:R145–R151
Leosco D, Femminella GD, de Lucia C, Rengo G (2014) Gene therapy using G protein-coupled receptors for the treatment of cardiovascular disease. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York NY, pp 333–345
Cannavo A, Rengo G, Liccardo D et al (2013) β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 reciprocal down-regulation influences cardiac hypertrophic response and progression toward heart failure: protective role of S1PR1 cardiac gene therapy. Circulation: Aug 22. epub ahead of print
Russell JL, Goetsch SC, Aguilar HR et al (2012) Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease. ACS Chem Biol 7:1077–1083
Yekkirala AS (2014) Novel mechanisms of G protein-coupled receptor oligomer and ion channel interactions in nociception. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 347–364
BÃró T, Tóth BI, Marincsák R et al (2007) TRP channels as novel players in the pathogenesis and therapy of itch. Biochim Biophys Acta 1772:1004–1021
Garcia MI, Fernandez-Vallone V, Vassart G (2014) Discovery and characterization of leucine-rich repeat-containing G protein-coupled receptors. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media, LLC, New York, pp 365–388
Styrkarsdottir U, Thorleifsson G, Sulem P et al (2013) Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature 497:517–520
Hsu HC, Liu YS, Tseng KC et al (2013) Overexpression of LGR5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer. Int J Colorectal Dis: Jun 20, epub ahead of print
Saigusa S, Inoue Y, Tanaka K et al (2013) Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemoradiotherapy. J Cancer Res Clin Oncol 139:131–138
Nakata S, Campos B, Bageritz J et al (2013) LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathol 23:60–72
Collette KM, Doze VA, Perez DM (2014) The role of G protein-coupled receptors in adult neurogenesis. In: Stevens CW (ed) Genetics of G protein-coupled receptors – research and methods in the post-genomic era. Methods in Pharmacology and Toxicology, Humana Press/Springer Science+Business Media LLC, New York NY, pp 389–411
Malberg JE (2004) Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci 29:196–205
Hanson ND, Owens MJ, Nemeroff CB (2011) Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 36:2589–2602
Acknowledgments
I would like to dedicate this volume to the memory of my mother, who is unfortunately losing hers. Much appreciation goes to my primary and secondary offspring, who were forced to face unpleasant circumstances but excelled in spite of them. Finally, I acknowledge the limitless support and encouragement of my significant other, the real doctor, who is my inspiration, my life, my everything.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Stevens, C.W. (2014). G Protein-Coupled Receptors: Research and Methods in the Post-Genomic Era. In: Stevens, C. (eds) G Protein-Coupled Receptor Genetics. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-779-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-62703-779-2_1
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-778-5
Online ISBN: 978-1-62703-779-2
eBook Packages: Springer Protocols